H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 271 000 KRW -2.34% Market Closed
Market Cap: 3T KRW
Have any thoughts about
Hugel Inc?
Write Note

Hugel Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hugel Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
H
Hugel Inc
KOSDAQ:145020
Operating Income
â‚©156.5B
CAGR 3-Years
14%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Operating Income
â‚©369.6B
CAGR 3-Years
-22%
CAGR 5-Years
6%
CAGR 10-Years
9%
SK Bioscience Co Ltd
KRX:302440
Operating Income
-â‚©12B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Operating Income
â‚©33.8B
CAGR 3-Years
-20%
CAGR 5-Years
-9%
CAGR 10-Years
-9%
P
PharmaResearch Co Ltd
KOSDAQ:214450
Operating Income
â‚©102.2B
CAGR 3-Years
31%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Operating Income
-â‚©8.1B
CAGR 3-Years
20%
CAGR 5-Years
4%
CAGR 10-Years
N/A
No Stocks Found

Hugel Inc
Glance View

Market Cap
3T KRW
Industry
Biotechnology

Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2015-12-24. The firm's product portfolio consists of botulinum toxins which used for treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50 unit types, 100 unit types and 200unit types; hyaluronic acid (HA) fillers which used for temporary removal of facial wrinkles including the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A and the chaeum VOLUS 20A; wellages, blue roses and other cosmetics. The firm sells its products in domestic and overseas markets.

Intrinsic Value
251 806.3 KRW
Overvaluation 7%
Intrinsic Value
Price
H

See Also

What is Hugel Inc's Operating Income?
Operating Income
156.5B KRW

Based on the financial report for Sep 30, 2024, Hugel Inc's Operating Income amounts to 156.5B KRW.

What is Hugel Inc's Operating Income growth rate?
Operating Income CAGR 5Y
19%

Over the last year, the Operating Income growth was 40%. The average annual Operating Income growth rates for Hugel Inc have been 14% over the past three years , 19% over the past five years .

Back to Top